SurModics, Inc. (NASDAQ:SRDX)

CAPS Rating: 2 out of 5

Develops, manufactures and markets innovative surface modification and drug delivery technologies for the healthcare industry.

Recs

0
Player Avatar HoldSideAnalyst (< 20) Submitted: 7/30/2007 5:23:31 PM : Outperform Start Price: $47.60 SRDX Score: -63.43

Stent worries overdone. Regardless, this company has real opportunities beyond the stent market.

Report this Post Reply

Featured Broker Partners


Advertisement